Announcements
Sidley Represents ModMed in Its Acquisition of Bonsai Health
April 22, 2026
Sidley is representing Clearlake Capital Group, L.P.-backed ModMed in its acquisition of Bonsai Health. ModMed is a leading provider of software and services to specialty medical practices, while Bonsai Health develops AI-driven patient engagement solutions tailored for healthcare providers. The acquisition will help ModMed in building out their AI-Powered Practice, a platform for bringing AI assistants to healthcare practitioners.
The Sidley team is led by Mehdi Khodadad and Mark Castiglia (M&A and Private Equity), and includes Thomas Guzman, Cameron Turkzadeh, and Edward Yu (M&A and Private Equity); Eric Kauffman (Employment); Stacy Crosnicker and Sarah Recktenwald (Employee Benefits and Executive Compensation); Jon Zucker and Jenna Hoskison (Healthcare); Lauren Kitces and Garrett Lance (Privacy and Cybersecurity); Jonathan Westreich, Greg Featherman, and Sophie Arkusinski (Tax); and Kyle Barnett, Dusan Clark, Andy Dykstra, and Natalie Crawford (Technology and Life Sciences Transactions).
The Sidley team is led by Mehdi Khodadad and Mark Castiglia (M&A and Private Equity), and includes Thomas Guzman, Cameron Turkzadeh, and Edward Yu (M&A and Private Equity); Eric Kauffman (Employment); Stacy Crosnicker and Sarah Recktenwald (Employee Benefits and Executive Compensation); Jon Zucker and Jenna Hoskison (Healthcare); Lauren Kitces and Garrett Lance (Privacy and Cybersecurity); Jonathan Westreich, Greg Featherman, and Sophie Arkusinski (Tax); and Kyle Barnett, Dusan Clark, Andy Dykstra, and Natalie Crawford (Technology and Life Sciences Transactions).
Contacts


Capabilities
Suggested News & Insights
Sidley Represents Churchill Downs in Its Acquisition of Preakness Intellectual Property RightsApril 22, 2026Sidley Represents Cboe Global Markets in Its US$300 Million Sale of Cboe Australia and Cboe Canada to TMX GroupApril 22, 2026Bad Investments, Not Bad Faith: Caremark Claims Have LimitsApril 21, 2026Sidley Represents Opus Genetics in US$155 Million Financing With Oberland CapitalApril 21, 2026Sidley Represents Galera Therapeutics in Its Merger With Obsidian Therapeutics and US$350 Million Private Placement FinancingApril 21, 2026Del. Ruling Shows Power of Postclose Governance Provisions in Earnout Disputes and Generative AI RiskApril 20, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory



